MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Interventions"

  • MDS Virtual Congress 2021

    Yoga for Functional Neurological Disorder – Two Case Descriptions

    D. Kipnis, H. Shah, L. Quinn (New York, USA)

    Objective: To describe key components of a yoga program for two individuals with Functional Neurological Disorder (FND). Background: FND is the second most common reason…
  • MDS Virtual Congress 2021

    Strategies for Social Prescribing: Combating Loneliness in Parkinson’s Disease

    I. Subramanian, J. Farahnik, L. Mischley (Los Angeles, USA)

    Objective: To examine the association between online social engagement (SE) including exercise & support groups, phone calls/video chats and daily outings with motor and non-motor…
  • MDS Virtual Congress 2021

    Experiences of home-based dance participation in people with Parkinson’s

    J. Bek, M. Groves, D. Leventhal, E. Poliakoff (Manchester, United Kingdom)

    Objective: To investigate experiences of people with PD in using digital resources for home-based dance participation during the COVID-19 pandemic. Background: Dance is associated with…
  • MDS Virtual Congress 2021

    Quality of life after Globus Pallidus vs Subthalamic nucleus DBS; insights from the Parkinson’s Outcomes Project registry.

    A. Ramirez-Zamora, M. Rafferty, N. Dahodwala, M. Neault, A. Naito, J. Beck, R. de Leon, S. Wu, C. Marras, T. Thomas (Gainesville, USA)

    Objective: To assess differences in quality of life between Globus Pallidus internus (Gpi) or Subthalamic (STN) nucleus deep brain stimulation (DBS) in Parkinson’s Disease (PD)…
  • MDS Virtual Congress 2021

    Happy to be home: Satisfaction with interdisciplinary home visits among individuals with advanced Parkinson’s Disease and their caregivers

    J. Fleisher, K. Woo, M. Levin, S. Hess, F. Akram, B. Ouyang, D. Hall, J. Chodosh (Chicago, USA)

    Objective: To compare satisfaction with medical care among people with advanced Parkinson’s Disease (PD) and their caregivers at baseline (best usual care in a tertiary…
  • MDS Virtual Congress 2021

    Utilizing digital biomarkers to explore risk factors for falls in patients with Lewy Body Dementia

    C. Battioui, A. Man, M. Pugh, J. Wang, X. Dang, H. Zhang, P. Ardayfio, L. Munsie, A M. Hake, K. Biglan (Indianapolis, USA)

    Objective: To analyze risk factors for falls in individuals with Lewy Body Dementia (LBD) enrolled in PRESENCE. Background: PRESENCE was a phase 2 clinical trial…
  • MDS Virtual Congress 2021

    Feasibility of Instituting Graduated High intensity Training (FIGHT-PD); Protocol for a non-contact boxing exercise study

    D. Blacker, R. Fazio, C. Tucak, M. Turner, S. Rajandran, T. Cruickshank (Nedlands, Australia)

    Objective: 1. To determine the feasibility and logistics of conducting a non-contact boxing exercise program for PD patients. 2. To determine the tolerability of the…
  • MDS Virtual Congress 2021

    Evaluating the use of digital biomarkers to test treatment effects on cognition and motor in patients with Lewy Body Dementia

    J. Wang, C. Battioui, A. Mccarthy, X. Dang, H. Zhang, A. Man, J. Kyle, L. Munsie, M. Pugh, K. Biglan (Indianapolis, USA)

    Objective: To evaluate if frequent cognitive and motor tests using an iPad app and a wrist-worn actigraphy watch to track activity and sleep can detect…
  • MDS Virtual Congress 2021

    Cinpanemab in Parkinson’s Disease: Imaging and Fluid Biomarker Results from the Phase 2 SPARK Study

    RM. Hutchison, K. Fraser, M. Yang, B. Hirschhorn, J. Xiao, D. Scott, B. Bedell, K. Evans, D. Graham, L. Martarello, J. Beaver, J. Cedarbaum, T. Fox, A. Siderowf, A. Lang (Cambridge, USA)

    Objective: To evaluate the effects of cinpanemab on biomarkers in participants with Parkinson’s disease (PD). Background: SPARK (NCT03318523) was designed to evaluate the safety, pharmacokinetics,…
  • MDS Virtual Congress 2021

    Re-thinking enrollment of Deep Brain Stimulation patients in Parkinson’s Disease Clinical Trials

    J. Jimenez-Shahed, J. Rosenow, S. Miocinovic, L. Luo, C. Aquino, D. Corcos, P. Agarwal (New York, USA)

    Objective: To report on a survey of Parkinson’s disease (PD) experts on the inclusion of PD patients with deep brain stimulation (DBS) in clinical trials.…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley